Wall Street Experts

Prognozy kwartalne Theravance Biopharma, Inc.


Dane w mln

3 12 2 11 10 1 9 0
Okres 2024-12-31 2024-12-31 2025-03-31 2025-03-31 2025-06-30 2025-06-30 2025-09-30 2025-09-30 2025-12-31 2025-12-31 2026-03-31 2026-03-31 2026-06-30 2026-06-30 2026-09-30 2026-09-30 2026-12-31 2026-12-31
Przychód (średnia) 17.03 17.03 15.57 15.57 15.92 15.92 17.61 17.61 41.14 41.14 18.69 18.69 18.73 18.73 20.62 20.62 25.62 25.62
Przychód Δ kw/kw -33.53% 0.00% -8.53% -8.53% 2.21% 2.21% 10.63% 10.63% 133.59% 133.59% -54.58% -54.58% 0.24% 0.24% 10.10% 10.10% 24.22% 24.22%
Przychód (min) 8.71 8.71 15.26 15.26 14.88 14.88 16.46 16.46 38.46 38.46 17.47 17.47 17.51 17.51 19.28 19.28 23.95 23.95
Przychód (max) 32.94 32.94 15.88 15.88 16.94 16.94 18.74 18.74 43.78 43.78 19.89 19.89 19.93 19.93 21.95 21.95 27.26 27.26
EBITDA (średnia) -14.78 -14.78 -13.52 -13.52 -13.82 -13.82 -15.29 -15.29 -35.71 -35.71 -16.22 -16.22 -16.26 -16.26 -17.90 -17.90 -22.24 -22.24
EBIT (średnia) -15.22 -15.22 -13.93 -13.93 -14.23 -14.23 -15.75 -15.75 -36.78 -36.78 -16.71 -16.71 -16.75 -16.75 -18.44 -18.44 -22.90 -22.90
EBIT % -89.41% -89.41% -89.41% -89.41% -89.41% -89.41% -89.41% -89.41% -89.41% -89.41% -89.41% -89.41% -89.41% -89.41% -89.41% -89.41% -89.41% -89.41%
Zysk netto (średni) -8.49 -8.49 -10.23 -10.23 -12.24 -12.24 -9.48 -9.48 11.97 11.97 -7.95 -7.95 -8.95 -8.95 -6.96 -6.96 -5.96 -5.96
Zysk netto % -49.85% -49.85% -65.67% -65.67% -76.86% -76.86% -53.85% -53.85% 29.11% 29.11% -42.56% -42.56% -47.77% -47.77% -33.74% -33.74% -23.28% -23.28%
EPS (średnia)
Liczba analityków (Przychody) 3 3 2 2 4 4 1 1 2 2 3 3 2 2 2 2 3 3
Liczba analityków (EPS) 2 2 1 1 2 2 1 1 1 1 1 1 1 1 1 1 1 1
symbol TBPH TBPH TBPH TBPH TBPH TBPH TBPH TBPH TBPH TBPH TBPH TBPH TBPH TBPH TBPH TBPH TBPH TBPH